The Medical Letter on Drugs and Therapeutics: Difference between revisions

*The Medical Letter on Drugs and Therapeutics*
Discipline	Pharmacology
Language	English, French, Italian
Publication details
History	1959-present
Publisher	The Medical Letter, Inc.
Frequency	Biweekly
Standard abbreviations;
ISO 4	Med. Lett. Drugs Ther.
Indexing;
CODEN	MELEAP
ISSN	1523-2859;
LCCN	00211546
OCLC no.	40606056
Links
	Journal homepage;

Browse history interactively

← Previous edit

Content deleted Content added

VisualWikitext

Inline

Latest revision as of 17:53, 6 January 2024

The Medical Letter on Drugs and Therapeutics (commonly referred to as The Medical Letter) is a peer-reviewed biweekly medical journal providing evaluations of pharmaceutical drugs. It is published in English, French, and Italian. The journal is abstracted and indexed in Index medicus/MEDLINE/PubMed. An offshoot, Treatment Guidelines from the Medical Letter (ISSN 1541-2792) was published from 2002 to 2014, when it was integrated into this journal.

Editorial process

Articles for The Medical Letter are drafted by either an editor or external consultant using both published and available unpublished studies that are reviewed for methodological rigor with special attention to the results of clinical trials. A preliminary draft is circulated to every member of the advisory board and 10-20 other investigators with relevant clinical or experimental experience with the article's topic. Drafts are also provided to the Food and Drug Administration and Centers for Disease Control and Prevention and to all first authors of articles cited in the text. The evaluation of each drug includes a discussion of its efficacy, side effects, and a comparison with older, more established agents. The final version of the paper includes comments from the reviewers and is checked and edited for accuracy and readability.^[1]

Publisher

The journal is published by The Medical Letter, Inc., a nonprofit organization founded in 1958 by Arthur Kallet and Harold Aaron.^[2] It is independent of the pharmaceutical industry, supported by subscriptions, accepts no advertising, and has had a strict policy in place that in order to retain its objectivity, no reprints will be sold to the pharmaceutical industry.^{[citation needed]}

References

^ "Flowchart of the editorial process" (PDF). The Medical Letter, Inc. Retrieved 2010-06-29.
^ "The Medical Letter - 50th Anniversary". The Medical Letter on Drugs and Therapeutics. 51 (1304): 5. 2009.

External links

Official website

[1] "Flowchart of the editorial process" (PDF). The Medical Letter, Inc. Retrieved 2010-06-29.

[2] "The Medical Letter - 50th Anniversary". The Medical Letter on Drugs and Therapeutics. 51 (1304): 5. 2009.

[1]

[2]

@@ Line 1: / Line 1: @@
+{{more citations needed|date=April 2016}}
-{{Infobox Journal
+{{Infobox journal
- | cover	=	<!--  Commented out because image was deleted: [[image:tml_on_drugs_w-website.gif|200px|center]] -->
+| cover = <!-- Commented out because image was deleted: [[image:tml on drugs w-website.gif|200px|center]] -->
-| discipline	=	[[Publication]]
+| discipline = [[Pharmacology]]
-| language	=	[[English language|English]], [[French language|French]], [[Italian language|Italian]], [[Japanese language|Japanese]],[[Spanish language|Spanish]] and a  [[Canadian adapted version]]
+| language = English, French, Italian
-| abbreviation	=	Med Lett Drugs Ther
+| abbreviation = Med. Lett. Drugs Ther.
-| publisher	=	[[The Medical Letter, Inc.]]
+| publisher = [[The Medical Letter, Inc.]]
-| country	=	[[USA]]
+| country =
-| history	=	first published 1959
+| history = 1959-present
-| website	=	http://www.medicalletter.org/
+| frequency = Biweekly
-| ISSN	=	1523-2859
+| website = http://secure.medicalletter.org/medicalletter
+| ISSN = 1523-2859
+| OCLC = 40606056
+| LCCN = 00211546
+| CODEN = MELEAP
 }}
+'''''The Medical Letter on Drugs and Therapeutics''''' (commonly referred to as ''The Medical Letter'') is a [[Peer review|peer-reviewed]] biweekly [[medical journal]] providing evaluations of [[pharmaceutical drug]]s. It is published in English, French, and Italian. The journal is abstracted and indexed in [[Index medicus]]/[[MEDLINE]]/[[PubMed]]. An offshoot, ''Treatment Guidelines from the Medical Letter'' ({{ISSN|1541-2792}}) was published from 2002 to 2014, when it was integrated into this journal.
+== Editorial process ==
-'''''The Medical Letter on Drugs and Therapeutics''''', commonly referred to as ''The Medical Letter'', provides independent, unbiased critical evaluations of new drugs and sometimes older drugs when important new information becomes available. The Medical Letter is well known as the "Gold Standard", for new drug review within the medical community for over five decades.
+Articles for ''The Medical Letter'' are drafted by either an editor or external consultant using both published and available unpublished studies that are reviewed for methodological rigor with special attention to the results of [[clinical trial]]s. A preliminary draft is circulated to every member of the advisory board and 10-20 other investigators with relevant clinical or experimental experience with the article's topic. Drafts are also provided to the [[Food and Drug Administration]] and [[Centers for Disease Control and Prevention]] and to all first authors of articles cited in the text. The evaluation of each drug includes a discussion of its efficacy, side effects, and a comparison with older, more established agents. The final version of the paper includes comments from the reviewers and is checked and edited for accuracy and readability.<ref>{{cite web |url=http://medlet-best.securesites.com/downloads/Editorialchart.pdf |title=Flowchart of the editorial process |accessdate=2010-06-29 |publisher=[[The Medical Letter, Inc.]] |format=PDF}}</ref>
+== Publisher ==
-The Medical Letter has a print and electronic circulation of well over 450,000 subscribers in 125 countries worldwide.
+The journal is published by The Medical Letter, Inc., a [[nonprofit organization]] founded in 1958 by [[Arthur Kallet]] and Harold Aaron.<ref>{{Cite journal |title=The Medical Letter - 50th Anniversary |url=https://secure.medicalletter.org/TML-article-1304d |journal=The Medical Letter on Drugs and Therapeutics |publication-date=2009 |volume=51 |issue=1304 |pages=5}}</ref> It is independent of the pharmaceutical industry,  supported  by subscriptions, accepts no advertising, and has had a strict policy in place that in order to retain its objectivity, no reprints will be sold to the pharmaceutical industry.{{citation needed|date=April 2016}}
+== References ==
-Published biweekly (26 issues/year), the newsletter is available in several languages: [[English language|English]] (US and Canadian editions), [[French language|French]] (Canadian and European editions), [[Italian language|Italian]], [[Japanese language|Japanese]], and [[Spanish language|Spanish]].The Medical Letter is also available as an electronic site license for institutions such as medical schools, hospitals and group practices.
+{{Reflist}}
+== External links ==
-''The Medical Letter'' is published by [[The Medical Letter, Inc.]], which also publishes the monthly ''[[Treatment Guidelines from The Medical Letter]]''.
+* {{Official website|http://secure.medicalletter.org/medicalletter}}
-== Editorial Process ==
-An expert consultant or one of the editors prepares the preliminary draft using both published and available unpublished studies that are carefully examined, paying special attention to the results of well controlled clinical trials.
-The preliminary draft is edited and sent to every member of the Advisory Board, to 10-20 other investigators who have clinical and experimental experience with the drug or type of drug or disease under review, to the [[Food and Drug Administration]] (FDA) and [[Centers for Disease Control and Prevention]] (CDC), to the first authors of all the articles cited in the text, to appropriate agents of the pharmaceutical companies making the drugs under review, and to drug companies that make similar compounds.  The evaluation of each drug includes a discussion of its efficacy, side effects, and a comparison with older, more established agents.
-Many critical observations, suggestions and questions are received from the reviewers and are incorporated into the article during the revision process, and the article is checked and edited to make sure the final appraisal is not only accurate, but also easy to read.
-[http://medlet-best.securesites.com/downloads/Editorialchart.pdf flowchart of the editorial process]
-== See also ==
-* ''[[New England Journal of Medicine]]''
-* ''[[Journal of the American Medical Association]]''
-* ''[[The Lancet]]''
-* ''[[British Medical Journal]]''
-* ''[[Annals of Internal Medicine]]''
-* ''[[Archives of Internal Medicine]]''
-* [[List of medical journals]]
-==External links==
-* [http://www.medicalletter.org The Medical Letter website]
-* [http://medlet-best.securesites.com/html/ed.htm The Medical Letter Editorial and Advisory Board]
-* [http://www.medicalletter.org/html/who.htm A short video representation of ''The Medical Letter'']
-* [http://www.medicalletter.org/html/institutions.htm Information regarding Group Site Licenses for Institutional Subscriptions to ''The Medical Letter'']
 {{DEFAULTSORT:Medical Letter on Drugs and Therapeutics}}
-[[Category:Medical journals]]
+[[Category:Academic journals established in 1959]]
-[[Category:Publications established in 1959]]
+[[Category:Pharmacology journals]]
+[[Category:Multilingual journals]]
+[[Category:English-language journals]]
+[[Category:French-language journals]]
+[[Category:Italian-language journals]]
+[[Category:English-Italian multilingual journals]]
+[[Category:Biweekly journals]]